Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab plus irinotecan in recurrent malignant glioma shows high overall survival in a multicenter retrospective pooled series of the Spanish Neuro-Oncology Research Group (GEINO).
Gil MJ, de Las Peñas R, Reynés G, Balañá C, Peréz-Segura P, García-Velasco A, Mesia C, Gallego O, Fernández-Chacón C, Martínez-García M, Herrero A, Andrés R, Benavides M, Quintanar T, Pérez-Martin X. Gil MJ, et al. Anticancer Drugs. 2012 Jul;23(6):659-65. doi: 10.1097/CAD.0b013e3283534d3e. Anticancer Drugs. 2012. PMID: 22634799
SEOM guideline for the treatment of malignant glioma.
Berrocal A, Gil M, Gallego Ó, Balaña C, Pérez Segura P, García-Mata J, Reynes G; SEOM (Spanish Society of Clinical Oncology). Berrocal A, et al. Clin Transl Oncol. 2012 Jul;14(7):545-50. doi: 10.1007/s12094-012-0839-6. Clin Transl Oncol. 2012. PMID: 22721801
Extended-schedule dose-dense temozolomide in refractory gliomas.
Berrocal A, Perez Segura P, Gil M, Balaña C, Garcia Lopez J, Yaya R, Rodríguez J, Reynes G, Gallego O, Iglesias L; GENOM Cooperative Group. Berrocal A, et al. J Neurooncol. 2010 Feb;96(3):417-22. doi: 10.1007/s11060-009-9980-7. Epub 2009 Aug 8. J Neurooncol. 2010. PMID: 19669096 Free PMC article. Clinical Trial.
Should we continue temozolomide beyond six cycles in the adjuvant treatment of glioblastoma without an evidence of clinical benefit? A cost analysis based on prescribing patterns in Spain.
Balañá C, Vaz MA, Lopez D, de la Peñas R, García-Bueno JM, Molina-Garrido MJ, Sepúlveda JM, Cano JM, Bugés C, Sanz SM, Arranz JL, Perez-Segura P, Rodriguez A, Martin JM, Benavides M, Gil M. Balañá C, et al. Among authors: gil m. Clin Transl Oncol. 2014 Mar;16(3):273-9. doi: 10.1007/s12094-013-1068-3. Epub 2013 Jun 21. Clin Transl Oncol. 2014. PMID: 23793813
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.
Gallego O, Cuatrecasas M, Benavides M, Segura PP, Berrocal A, Erill N, Colomer A, Quintana MJ, Balaña C, Gil M, Gallardo A, Murata P, Barnadas A. Gallego O, et al. Among authors: gil m. J Neurooncol. 2014 Jan;116(2):413-9. doi: 10.1007/s11060-013-1316-y. Epub 2013 Dec 19. J Neurooncol. 2014. PMID: 24352766 Free PMC article.
Efficacy of radiotherapy for malignant gliomas in elderly patients.
Villà S, Viñolas N, Verger E, Yaya R, Martínez A, Gil M, Moreno V, Caral L, Graus F. Villà S, et al. Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):977-80. doi: 10.1016/s0360-3016(98)00356-3. Int J Radiat Oncol Biol Phys. 1998. PMID: 9869218
Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.
Subirá D, Serrano C, Castañón S, Gonzalo R, Illán J, Pardo J, Martínez-García M, Millastre E, Aparisi F, Navarro M, Dómine M, Gil-Bazo I, Pérez Segura P, Gil M, Bruna J. Subirá D, et al. Neuro Oncol. 2012 Jan;14(1):43-52. doi: 10.1093/neuonc/nor172. Epub 2011 Oct 12. Neuro Oncol. 2012. PMID: 21993441 Free PMC article.
198 results